Pinned post
What an absolute honor to chair the papillary RCC Education Session at #ASCO26! ๐๐ฌ
Papillary renal cell carcinoma is a disease that demands our attention, and this session covered the full spectrum ๐งฌ โ biology โก๏ธ frontline โก๏ธ refractory disease.
I was thrilled to review subsequent lines + novel therapeutic approaches for refractory papillary RCC ๐๐, including the emerging strategies and clinical trial opportunities that give me so much hope for our patients. ๐
Huge thanks to my incredible co-faculty Dr. Ramaprasad Srinivasan ๐ง & @charlesbnguyen for such an engaging discussion โ collaboration like this is what moves the field forward! ๐
#KidneyCancer #RCC #GUOncology @ASCO @urotoday @JCO_ASCO @ASCOPost @charlesbnguyen @OncoAlert @UCSF
Papillary renal cell carcinoma is a disease that demands our attention, and this session covered the full spectrum ๐งฌ โ biology โก๏ธ frontline โก๏ธ refractory disease.
I was thrilled to review subsequent lines + novel therapeutic approaches for refractory papillary RCC ๐๐, including the emerging strategies and clinical trial opportunities that give me so much hope for our patients. ๐
Huge thanks to my incredible co-faculty Dr. Ramaprasad Srinivasan ๐ง & @charlesbnguyen for such an engaging discussion โ collaboration like this is what moves the field forward! ๐
#KidneyCancer #RCC #GUOncology @ASCO @urotoday @JCO_ASCO @ASCOPost @charlesbnguyen @OncoAlert @UCSF